These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31587819)

  • 1. Effect of financial incentives on breast, cervical and colorectal cancer screening delivery rates: Results from a systematic literature review.
    Mauro M; Rotundo G; Giancotti M
    Health Policy; 2019 Dec; 123(12):1210-1220. PubMed ID: 31587819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are GPs' preferences for financial and non-financial incentives in cancer screening? Evidence for breast, cervical, and colorectal cancers.
    Sicsic J; Krucien N; Franc C
    Soc Sci Med; 2016 Oct; 167():116-27. PubMed ID: 27619755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of payment incentives on cancer screening in Ontario primary care.
    Kiran T; Wilton AS; Moineddin R; Paszat L; Glazier RH
    Ann Fam Med; 2014 Jul; 12(4):317-23. PubMed ID: 25024239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-centered medical home implementation and use of preventive services: the role of practice socioeconomic context.
    Markovitz AR; Alexander JA; Lantz PM; Paustian ML
    JAMA Intern Med; 2015 Apr; 175(4):598-606. PubMed ID: 25686468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates.
    Kaczorowski J; Hearps SJ; Lohfeld L; Goeree R; Donald F; Burgess K; Sebaldt RJ
    Can Fam Physician; 2013 Jun; 59(6):e282-9. PubMed ID: 23766067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial Incentives and Cervical Cancer Screening Participation in Ontario's Primary Care Practice Models.
    Pendrith C; Thind A; Zaric GS; Sarma S
    Healthc Policy; 2016 Aug; 12(1):116-28. PubMed ID: 27585031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of financial incentives on the quality of health care provided by primary care physicians.
    Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of Financial Incentives to Mailed Outreach for Promoting Colorectal Cancer Screening: A Systematic Review and Meta-analysis.
    Facciorusso A; Demb J; Mohan BP; Gupta S; Singh S
    JAMA Netw Open; 2021 Aug; 4(8):e2122581. PubMed ID: 34432010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data.
    Sicsic J; Franc C
    Eur J Health Econ; 2017 Jun; 18(5):609-621. PubMed ID: 27329654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States.
    Escoffery C; Rodgers KC; Kegler MC; Haardörfer R; Howard DH; Liang S; Pinsker E; Roland KB; Allen JD; Ory MG; Bastani R; Fernandez ME; Risendal BC; Byrd TL; Coronado GD
    BMC Public Health; 2014 Mar; 14():274. PubMed ID: 24661503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practice Facilitation and Academic Detailing Intervention Can Improve Cancer Screening Rates in Primary Care Safety Net Clinics.
    Mader EM; Fox CH; Epling JW; Noronha GJ; Swanger CM; Wisniewski AM; Vitale K; Norton AL; Morley CP
    J Am Board Fam Med; 2016; 29(5):533-42. PubMed ID: 27613786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
    Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
    Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and cervical cancer screening services in Malawi: a systematic review.
    Pittalis C; Panteli E; Schouten E; Magongwa I; Gajewski J
    BMC Cancer; 2020 Nov; 20(1):1101. PubMed ID: 33183270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of marital status on the use of breast, cervical, and colorectal cancer screening.
    Hanske J; Meyer CP; Sammon JD; Choueiri TK; Menon M; Lipsitz SR; Noldus J; Nguyen PL; Sun M; Trinh QD
    Prev Med; 2016 Aug; 89():140-145. PubMed ID: 27215758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening.
    Community Preventive Services Task Force
    Am J Prev Med; 2012 Jul; 43(1):92-6. PubMed ID: 22704753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General practitioners’ preferences towards incentive measures linked with cancer screening].
    Sicsic J; Franc C
    Sante Publique; 2019; S2(HS2):33-41. PubMed ID: 32372577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review.
    Bongaerts TH; Büchner FL; Middelkoop BJ; Guicherit OR; Numans ME
    J Med Screen; 2020 Sep; 27(3):121-129. PubMed ID: 31801039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.